Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Non Operating Income (2016 - 2025)

Iradimed (IRMD) has disclosed Non Operating Income for 13 consecutive years, with $463976.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 26.26% to $463976.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 9.92% decrease, with the full-year FY2024 number at $2.3 million, up 35.7% from a year prior.
  • Non Operating Income was $463976.0 for Q3 2025 at Iradimed, down from $539247.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $642217.0 in Q2 2024 to a low of -$14915.0 in Q1 2022.
  • A 5-year average of $321180.7 and a median of $449733.0 in 2022 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 11343.59% in 2022; the steepest drop was 163.38% in 2022.
  • Iradimed's Non Operating Income stood at $3930.0 in 2021, then surged by 11343.59% to $449733.0 in 2022, then grew by 16.03% to $521810.0 in 2023, then rose by 4.28% to $544160.0 in 2024, then decreased by 14.74% to $463976.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Non Operating Income are $463976.0 (Q3 2025), $539247.0 (Q2 2025), and $513973.0 (Q1 2025).